AKT1 and thyroid gland carcinoma: Single or combined use of RDEA119 (a MAPK pathway inhibitor) and perifosine (a PI3K/Akt pathway inhibitor) could increase the expression of iodide-handling genes in 11 thyroid cancer cell lines.